查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197263

工业微生物学测试市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Industrial Microbiology Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2023 年至 2028 年），工业微生物检测市场预计将以 6.9% 的复合年增长率增长。

COVID-19 大流行的出现对全球经济产生了重大影响，不仅影响医疗保健行业，也影响其他行业。 世界各国政府为遏制 COVID-19 的传播而实施的限制扰乱了製药和生物技术供应链之外的製造、样品测试、研发活动等服务，并对工业微生物学市场产生了影响。 例如，根据 2021 年 10 月发表的题为“COVID-19 对南亚农业生产和分配的影响”的研究，印度、孟加拉国和巴基斯坦发现 COVID-19 在收穫季节出现，导致活动据说这些国家的农产品生产和流通等都受到了很大影响。

然而，根据 Elsevier 公共卫生紧急情况合集于 2021 年 12 月在大流行之前发表的一篇题为“冠状病毒大流行期间膳食补充剂和营养保健品市场增长——对消费者和监管的影响”的文章，观察到以下情况。 与 2019 年同期相比，2019 年营养补充剂销售额增长 5%，达到 3.45 亿美元，在 2020 年 4 月 5 日第一波大流行之前的六週内，销售额增长了 44%（4.35 亿美元）。 此外，根据同一消息来源，2020 年 3 月美国复合维生素的销售额增长了 51.2%，在此期间销售了近 1.2 亿种维生素和补充剂。 此外，2020 年 3 月维生素在英国的销售额增长了 63%，在法国的销售额增长了约 40-60%。 这样，用于维持和改善免疫系统的多种维生素和益生菌的销量在每个国家都在增加，预计这将对调查市场产生重大影响。 同样，COVID-19 也导致了全球各行业微生物检测的新规范。 由于 COVID-19 病例数量下降，所研究的市场有望在研究预测期内恢復其全部潜力。

营养保健品和发酵食品在世界范围内越来越受欢迎，并在食品安全方面发挥着重要作用。 因此，随着世界对它们的需求增加，对高级检测以保持产品质量和完整性的需求也在增加。 因此，全球对工业微生物学产品的需求正在增加，预计将成为本研究预测期内工业微生物学市场增长的主要因素。 例如，根据印度政府食品加工工业部的数据，2020 年印度的保健食品市场规模为 40 亿美元。 此外，根据同一消息来源，该国的膳食补充剂市场预计从 2019 年到 2024 年将增长 7%。 印度人开始相信增强免疫力的补充剂，消费者和市场行为的购买模式也发生了重大转变。 此外，美国在临床营养方面取得了许多进步。 例如，2021 年 11 月，雅培宣布推出 Similac 360 Total Care，这是美国首款也是唯一一款将五种母乳低聚醣 (HMO) 混合在一起的婴儿配方奶粉，此前仅在母乳中才能发现。 本产品提供营养以支持宝宝的全面健康和发育，包括免疫系统、消化系统和大脑。 维生素胶囊和咀嚼片等膳食补充剂在全球范围内的需求不断增加，以治疗各种疾病，尤其是儿童和老年人，并且对微生物检测以确保产品质量的需求不断增长。预计工业微生物检测市场将在预测期预计会增加。

预计会对工业微生物检测市场产生积极影响的其他主要因素包括增加工业微生物检测的研发支出、改进或加强工业微生物检测程序、推出新的和先进的产品。 例如，2022 年 6 月，STEMart 推出了针对无菌、无热原产品的全面微生物和无菌测试服务。 此外，2021 年 12 月，在印度，AKTA Nutrition 与 Sundyota Numandis Group 合作推出了一系列采用优质原材料的营养补充剂产品。 产品包括 Bye-Bye Stress（促进放鬆和睡眠）、Good Immunity（促进身体抵抗感染的自然能力）和 Beet Strong（增加甜菜的益处以促进整体健康）。 同样，2020 年 7 月，Neogen Co., Ltd. 推出了 Soleris Next Generation (NG)，这是一种先进的测试系统，与传统测试方法相比，它可以在很短的时间内自动检测微生物。 我们快速检测多种微生物，并提供安全、优质的食品和化妆品。 因此，预计产品发布的增加和企业活动的增加将增加对微生物检测产品的需求，从而推动预测期内的市场增长。

但是，预计在预测期内，食品来源中使用转基因生物的争议和产品召回的增加等因素将抑制工业微生物检测市场的增长。

工业微生物检测市场趋势

在预测期内，製药和生物技术行业预计将占据工业微生物检测市场的很大份额

由于研发活动的增加、救生药物的生产和各种适应症的治疗，特别是抗生素和抗菌剂的生产等因素，预计製药和生物技术行业在预测期内将实现市场增长。预计将录得显着增长 随着全球对药物和疗法的需求不断增加，微生物学在製药和生物技术行业中的作用也在增加，这有望推动研究学科领域的发展。

全球製药和生物技术公司不断增加的研发支出预计将成为所研究市场的製药和生物技术行业在研究预测期内增长的主要驱动力。 例如，美国国会预算办公室公布的数据证实，2021 年 6 月，製药行业将在全球范围内投入近 2000 亿美元用于研发，而 2019 年为 8300 万美元。 此外，Becton, Dickinson, and Company 在 2021 财年的研发活动支出为 13.39 亿美元，而 2020 财年为 10.96 亿美元。 同样，Thermo Fisher Scientific Inc. 在 2021 财年的研发活动支出为 14.06 亿美元，而 2020 财年为 11.81 亿美元。 因此，随着研发支出的增加，预计製药和生物技术行业将在预测期内占据所研究市场的很大份额。

此外，2020 年 7 月，20 多家领先的生物製药公司联合成立了抗菌素耐药性 (AMR) 行动基金。 这一开创性的合作伙伴关係旨在到 2030 年为患者带来 2-4 种新型抗生素，投资近 10 亿美元帮助对抗最具耐药性的细菌和致命感染。目的是资助针对创新型新型抗生素的临床研究 预计这将有助于预测期内市场的增长。

因此，由于上述因素，预计在本研究的预测期内，製药和生物技术行业将占据工业微生物检测市场的主要份额。

北美主导市场，预计在预测期内也会如此

北美的製药、生物技术和食品行业对新产品研发进行了大量投资，该地区对营养补充剂和发酵产品的需求不断增长，并且该地区的产品发布预计将占据主导地位由于在预测期内的增加，市场份额很大 例如，根据加拿大统计局 2021 年 5 月的报告，2019 年加拿大製药业在研发上的支出在 15 亿美元至 40 亿美元之间，其中 20 亿美元和 1.5 亿美元用于国内和国际外包研发业务。 因此，由于上述因素，预计北美地区在所研究市场的预测期内将占据很大份额。

在北美地区，大型製药和食品公司的存在，以及在该国开设新测试设施和该地区主要市场参与者推出新产品以及扩张，已经导致 预计将占据被研究市场的很大份额。 例如，2022 年 6 月，SGS 在亚利桑那州凤凰城开设了生物安全二级微生物实验室。 此次发布将使该公司能够为在该地区运营的公司提供更多本地化和专业化的测试。 此外，2021 年 5 月，Becton、Dickinson 和 Company 在美国推出了尿液培养应用程序，用于 BD Kiestra 实验室自动化孵化和成像系统。 因此，预计在该地区推出更多产品将促进市场增长。

此外，製药和生物技术公司越来越多地采用合作伙伴关係和协议等各种商业战略，预计也将在预测期内推动市场增长。 例如，2020 年 7 月，Baxter International, Inc. 与 VIPUN Medical 达成协议，将 VIPUN 胃监测系统商业化。 通过使用专为测量胃动力而设计的智能肠内餵养管，重症监护病房 (ICU) 等临床医生可以更准确地识别肠内餵养阻力并为营养治疗决策提供信息。您可以做到。

因此，由于上述因素，预测期内该地区的工业微生物检测市场有望显着增长。

工业微生物检测市场竞争者分析

工业微生物检测市场竞争相当激烈，因为在不同的地理位置存在多家公司，这些公司能够通过提供其所在地区的最新产品在国内和国际上展开竞争。我们支持不同的行业在国际水平上发展. 该市场的主要参与者包括 bioMerieux SA、Bio-Rad Laboratories、Thermo Fisher Scientific Inc.、Becton、Dickinson and Company、Qiagen NV 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 越来越偏爱膳食补充剂和其他发酵产品
    • 研发费用增加，技术创新取得进展
    • 人们对食品安全的担忧加剧
  • 市场製约因素
    • 关于在食物来源中使用转基因生物的争议
    • 产品召回率增加
  • 五力分析分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 设备/系统
    • 消耗品
    • 试剂
  • 按应用领域
    • 食品和饮料行业
    • 製药/生物技术
    • 农业
    • 环保行业
    • 化妆品和个人护理行业
    • 其他应用领域
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • 3M Company
    • Agilent Technologies
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Eppendorf AG
    • Qiagen NV
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Asiagel Corporation

第7章 市场机会与今后动向

简介目录
Product Code: 62779

The industrial microbiology market is expected to register a CAGR of 6.9% during the forecast period (2023 - 2028).

The emergence of the COVID-19 pandemic had a significant impact on the global economy, which not only impacted the healthcare sector but other sectors too. The restrictions imposed by respective governments across the world to curb the spread of infections led to disruption in services like manufacturing, sample testing, research, and development activities other than COVID-19, pharmaceutical and biotechnology supply chain, which had their impact on the industrial microbiology market. For instance, according to the research study published in October 2021, titled "Impact of COVID-19 on agricultural production and distribution in South Asia", in India, Bangladesh, and Pakistan, the agriculture sector was severely impacted as the COVID-19 emerged in these regions during harvest time, and thus, production, distribution and other activities were impacted for agriculture products in these countries.

However, according to an article published by the Elsevier Public Health Emergency Collection, in December 2021, titled "Dietary supplements and nutraceuticals market growth during the coronavirus pandemic - Implications for consumers and regulatory oversight", it has been observed that before the pandemic, the dietary supplement sales in the United States increased by 5% to USD 345 million in 2019 and there was a 44% (USD 435 million) rise in sales in the six weeks before April 5th, 2020, during the first wave of the pandemic as compared to the same period in 2019. In addition, as per the same source, multivitamin sales increased by 51.2% in March 2020 in the United States, and nearly 120 million units of vitamins and supplements were sold during that period. Furthermore, vitamin sales increased by 63% in the United Kingdom, and in France, sales grew by approximately 40-60% in March 2020. Thus, the increased sales of multivitamins, probiotics, and other products in the countries to maintain and improve the immune system is expected to significantly impact the studied market. Likewise, COVID-19 also led to new norms for microbial testing in various industries worldwide. With decreasing COVID-19 cases, the studied market is expected to regain its full potential during the forecast period of the study.

Nutraceutical and fermented food products are gaining traction worldwide and playing an important role in food security; thus, with an increase in their global demand, the need for advanced testing is also increasing to maintain the quality and integrity of the products. Hence, the demand for products used in industrial microbiology is increasing worldwide, which is expected to be a major growth factor for the growth of the industrial microbiology market during the forecast period of the study. For instance, according to the Ministry of Food Processing Industries of the Government of India, the nutraceuticals market was USD 4 billion in India in 2020. Further, as to the same source, the nutraceutical market is expected to grow by 7% from 2019 to 2024 in the country. The Indian population has started to believe in immunity-boosting supplements, which has significantly changed buying patterns of consumer behavior and market behavior. Additionally, the United States saw many developments concerning clinical nutrition. For instance, in November 2021, Abbott launched Similac 360 Total Care, the first and only infant formula in the United States with a blend of five different Human Milk Oligosaccharides (HMOs), previously only found together in breast milk. The product provides nutrition to support a baby's complete health and development, including the immune system, digestive system, and brain. With the increasing demand for vitamin capsules, chewable tablets, and other nutraceutical products for treating various conditions in populations, especially pediatric and geriatric populations, all over the world is expected to increase the demand for microbiology testing to assuring the quality of the products and thus, the industrial microbiology market is expected to grow over the forecast period.

Other major factors that are expected to positively impact the industrial microbiology market include increasing research and development expenditure in industrial microbiology and the launch of new and advanced products that can improve or enhance industrial microbiology procedures. For instance, in June 2022, STEMart launched comprehensive microbiological and sterility testing services for sterile, non-pyrogenic products. Additionally, in December 2021, in India, AKTA Nutrition partnered with Sundyota Numandis Group to launch a nutraceutical product line utilizing quality ingredients. The product offerings include Bye-Bye Stress (which promotes relaxation and sleep), Good Immunity (which promotes the body's natural capacity to fight against infections), and Beet Strong (which promotes overall well-being with added benefits of beetroot). Similarly, in July 2020, Neogen Corporation launched an advanced test system, Soleris Next Generation (NG), which automatically detects microorganisms in a fraction of the time of traditional testing methods. The system rapidly detects a wide variety of microorganisms to provide safe and high-quality food and cosmetic products. Thus, increasing product launches and rising company activities are expected to increase the demand for microbiology testing products which is anticipated to fuel the market growth over the forecast period.

However, factors such as conflicts regarding the usage of genetically modified organisms in food sources and increasing product recalls are expected to restrain the growth of the industrial microbiology market during the forecast period.

Industrial Microbiology Market Trends

Pharmaceutical and Biotechnology Industry Segment is Expected to Have a Significant Share in the Industrial Microbiology Market During Forecast Period

The pharmaceutical and biotechnology industry segment is expected to register significant growth in the market over the forecast period owing to the factors such as increasing research and development activities, and the manufacturing of life-saving drugs and therapies for various indications, especially in the manufacturing of antibiotics or antimicrobials. With the increasing demand for drugs and therapies around the world, the role of microbiology is also expected to increase in the pharmaceutical and biotechnology industry, which is expected to fuel growth in the studied segment.

The increasing research and development expenditure by the pharmaceutical and biotechnology companies around the world is expected to be the major driving factor for the growth in the pharmaceutical and biotechnology industry in the studied market over the forecast period of the study. For instance, according to the data published by the Congressional Budget Office, in June 2021, it has been observed that pharmaceutical industries have spent nearly USD 200 billion on research and development globally compared to USD 83 million in 2019. Additionally, Becton, Dickinson, and Company spent USD 1,339 million on its research and development activities in FY2021 compared to USD 1,096 million in FY2020. Similarly, Thermo Fisher Scientific Inc. spent USD 1,406 million on its research and development activities in FY2021 compared to USD 1,181 million in FY2020. Thus, with the increasing research and development expenditure, the pharmaceutical and biotechnology industry is expected to hold a significant share in the studied market over the forecast period.

Furthermore, in July 2020, over 20 leading biopharmaceutical companies joined forces to form the Antimicrobial Resistance (AMR) Action Fund, which is a ground-breaking partnership that aims to bring 2 to 4 new antibiotics to patients by 2030, with an investment of about USD 1 billion to fund and support clinical research of innovative new antibiotics that target the most resistant bacteria and fatal infections. This is expected to contribute to the growth of the market over the forecast period.

Therefore, owing to the above-mentioned factors, the pharmaceutical and biotechnology industry is expected to hold a major share in the industrial microbiology market over the forecast period of the study.

North America Dominates the Market and Expects to do Same in the Forecast Period

North America is expected to dominate the market with a significant share over the forecast period owing to a significant investment by the pharmaceutical, biotechnology, and food industry in the research and development of new products, along with growing demand for nutraceuticals and fermented products in the region and increasing product launches in the region. For instance, according to the May 2021 report of Statistics Canada, between USD 1.5 and USD 4.0 billion was spent on research and development by the Canadian pharmaceutical sector in 2019, of which USD 2 billion was spent on in-house research and USD 950 million spent on outsourcing research and development work, both domestically and outside Canada. Thus, due to these mentioned factors, the North American region is expected to hold a significant share in the studied market over the forecast period of the study.

In the North American region, the United States is expected to occupy a major share in the studied market due to the factors such as the presence of large-scale pharmaceutical and food companies, and the launch of new products along with the opening and expansion of new testing facilities in the country by key market players in the region. For instance, in June 2022, SGS launched a Biosafety Level-2 microbiology lab in Phoenix, Arizona. With this launch, the company can offer more localized specialist testing for companies operating in the region. Additionally, in May 2021, Becton, Dickinson, and Company launched Urine Culture Application for use with the BD Kiestra lab automation incubation and imaging system in the United States. Thus, increasing launches in the region are expected to boost the market growth.

Furthermore, the rising adoption of various business strategies such as partnerships and agreements by the pharmaceutical and biotechnology companies are also expected to increase the market growth over the forecast period. For instance, in July 2020, Baxter International Inc. signed an agreement with VIPUN Medical to commercialize the VIPUN Gastric Monitoring System. Using a smart enteral feeding tube designed to measure stomach motility, clinicians in the intensive care unit (ICU) and other settings can more accurately identify enteral feeding resistance and make decisions about nutrition therapy.

Hence, owing to the above-mentioned factors, the industrial microbiology market is expected to grow significantly over the forecast period in the region.

Industrial Microbiology Market Competitor Analysis

There are several companies in the industrial microbiology market across different geographical locations, which is why the market is fairly competitive, and these companies support different industries to grow at the domestic and international levels by offering the latest products in the area. Some of the major players in this market include bioMerieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, and Qiagen NV, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Preference for Nutraceuticals and Other Fermented Products
    • 4.2.2 Increasing Research and Development Expenditure and Increasing Innovation
    • 4.2.3 Rising Concern for Food Safety
  • 4.3 Market Restraints
    • 4.3.1 Conflicts Regarding Usage of Genetically Modified Organisms in Food Sources
    • 4.3.2 Increasing Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value- USD Million)

  • 5.1 By Product Type
    • 5.1.1 Equipment and Systems
    • 5.1.2 Consumables
    • 5.1.3 Reagents
  • 5.2 By Application Area
    • 5.2.1 Food and Beverage Industry
    • 5.2.2 Pharmaceutical and Biotechnology Industry
    • 5.2.3 Agricultural Industry
    • 5.2.4 Environmental Industry
    • 5.2.5 Cosmetic or Personal Care Industry
    • 5.2.6 Other Application Areas
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M Company
    • 6.1.2 Agilent Technologies
    • 6.1.3 Becton Dickinson and Company
    • 6.1.4 BioMerieux SA
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 Danaher Corporation
    • 6.1.7 Eppendorf AG
    • 6.1.8 Qiagen NV
    • 6.1.9 Merck KGaA
    • 6.1.10 Thermo Fisher Scientific Inc.
    • 6.1.11 Sartorius AG
    • 6.1.12 Asiagel Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS